Nigeria Cannabis Policy — Legal Status, Reform Debates, and Economic Impact

Executive Summary

Nigeria maintains one of Africa's strictest cannabis prohibition regimes despite growing continental momentum toward reform and significant domestic cultivation. The Nigerian government's destruction of ₦16 billion (approximately $10.4 million USD) worth of seized cannabis in May 2026 reignited fierce debate over the country's cannabis policy, with activists including Omoyele Sowore condemning the action as economically wasteful and medically regressive. Nigeria's Indian Hemp Act of 1966 criminalizes all cannabis cultivation, possession, and distribution, imposing penalties up to life imprisonment for trafficking offenses. While neighboring countries including South Africa, Lesotho, Zimbabwe, and Ghana have moved toward medical cannabis frameworks, Nigeria has resisted reform despite documented traditional medicinal use, substantial illicit cultivation in states including Ondo and Edo, and potential agricultural revenue estimated in billions of naira annually. The policy debate centers on medical access, economic opportunity, religious and cultural concerns, and law enforcement resource allocation, with reform advocates arguing that prohibition has failed to curb cultivation while denying patients access and the treasury legitimate tax revenue.

Why This Matters

Nigeria's cannabis policy affects 220 million citizens, shapes West African drug enforcement cooperation, and determines whether Africa's most populous nation will participate in the global medical cannabis market projected to exceed $57 billion by 2028. The May 2026 destruction of ₦16 billion worth of cannabis by the Nigeria Customs Service represents more than symbolic enforcement—it reflects foregone medical research opportunities, lost agricultural revenue, and continued criminalization of an estimated 7.4 million Nigerian cannabis users according to United Nations Office on Drugs and Crime data. For patients suffering from epilepsy, chronic pain, and cancer-related symptoms, prohibition means no legal access to cannabinoid therapies available in 40+ countries globally. Economically, Nigeria's prohibition stance excludes the nation from participating in Africa's emerging cannabis export market. Lesotho, with a population of 2.1 million, generated $1.8 million in cannabis export revenue in 2023, while Nigeria—with 100 times the population and superior agricultural conditions—generates zero legal cannabis revenue. Agricultural economists estimate that regulated cannabis cultivation could generate ₦300-500 billion annually in a mature market, creating employment for smallholder farmers in states where cannabis already grows prolifically. The policy also shapes regional security dynamics. Nigeria's porous borders with Benin, Niger, Chad, and Cameroon make unilateral prohibition difficult to enforce, with cannabis flowing across borders regardless of legal status. Law enforcement resources dedicated to cannabis interdiction—including the recent ₦16 billion seizure operation—divert capacity from combating human trafficking, arms smuggling, and violent extremism in the Northeast.

Background and History

Cannabis prohibition in Nigeria traces to colonial-era legislation adopted without consideration of indigenous medicinal traditions or post-independence agricultural policy.

Pre-Colonial and Colonial Period (Pre-1960)

Cannabis cultivation and use in West Africa predates European colonization by centuries. Ethnobotanical research documents cannabis use among Yoruba traditional healers for treating convulsions, and among Hausa communities for pain management and appetite stimulation. The plant, known locally as "igbo" in southeastern Nigeria and "wiwi" in Yoruba regions, grew wild and was cultivated on small scales for medicinal and ritual purposes. British colonial authorities introduced cannabis restrictions in Nigeria during the 1930s as part of broader imperial drug control efforts following the 1925 International Opium Convention. The colonial government classified cannabis alongside opium and cocaine despite its distinct pharmacology and traditional use patterns. These restrictions remained loosely enforced during the colonial period, with cannabis cultivation continuing in rural areas outside administrative reach.

Post-Independence Criminalization (1960-1990)

Nigeria gained independence on October 1, 1960, but retained colonial-era drug laws initially. The watershed moment came with the Indian Hemp Act of 1966, enacted by the military government of General Johnson Aguiyi-Ironsi. This legislation, still in force today, criminalized all cannabis cultivation, possession, sale, and importation without exception for medical or research purposes. The Act imposed severe penalties: up to four years imprisonment for possession, up to 21 years for cultivation or sale, and life imprisonment for trafficking. The legislation defined "Indian hemp" broadly to include "any part of any plant of the genus Cannabis" and "any mixture of vegetable matter containing any proportion of Indian hemp," leaving no room for CBD-only products or hemp cultivation. The 1966 Act reflected Cold War-era international pressure for drug prohibition rather than domestic Nigerian policy priorities. The United States, through bilateral aid programs, encouraged strict drug enforcement throughout Africa during this period. Nigeria's military governments, seeking international legitimacy and foreign aid, adopted prohibition frameworks aligned with U.S. preferences. Cannabis cultivation nevertheless continued, particularly in Ondo State's forested areas and Edo State's agricultural zones. By the 1980s, Nigerian cannabis—particularly strains cultivated in Ondo—gained regional recognition for potency, creating cross-border trade networks extending to Ghana, Benin, and Cameroon.

NDLEA Establishment and Enforcement Escalation (1990-2010)

Nigeria established the National Drug Law Enforcement Agency in 1990 through Decree No. 48, creating a dedicated federal agency for drug enforcement. NDLEA received broad powers including arrest without warrant, asset seizure, and prosecution authority. The agency's founding reflected Nigeria's commitment to the 1988 UN Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. NDLEA focused significant resources on cannabis eradication, conducting annual operations to destroy cannabis farms in Ondo, Edo, Osun, and Oyo states. Between 1990 and 2010, NDLEA reported destroying over 3,000 hectares of cannabis cultivation and seizing more than 2 million kilograms of cannabis products. These operations often involved military support and resulted in arrests of thousands of farmers, many of whom received multi-year prison sentences. Despite intensive enforcement, cannabis cultivation persisted and arguably expanded. The economic incentives remained powerful—a hectare of cannabis could generate 10-20 times the revenue of traditional crops like cassava or yams. Farmers developed increasingly sophisticated cultivation techniques, including forest intercropping and rapid-harvest varieties, to evade detection.

Continental Reform Wave and Nigerian Resistance (2010-Present)

The 2010s brought significant cannabis policy reform across Africa, creating pressure on Nigeria to reconsider its stance. South Africa's Constitutional Court decriminalized private adult cannabis use in September 2018 in the landmark Prince v. President of the Law Society of the Cape of Good Hope case. Lesotho legalized medical cannabis cultivation in 2017, becoming the first African nation to do so. Zimbabwe followed in 2018, Ghana launched medical cannabis pilot programs in 2020, and Zambia legalized cultivation for export in 2023. Nigeria resisted this reform wave. In 2020, the Nigerian House of Representatives rejected a bill that would have legalized medical cannabis and hemp cultivation. The bill, sponsored by Representative Nicholas Ossai, proposed licensing medical cannabis production and allowing CBD products with less than 0.3% THC. Religious groups, led by the Christian Association of Nigeria and the Supreme Council for Islamic Affairs, opposed the legislation, arguing that any cannabis legalization would undermine moral values and increase recreational use. The National Agency for Food and Drug Administration and Control maintained its prohibition stance, refusing to approve any cannabis-derived medications including FDA-approved drugs like Epidiolex (cannabidiol oral solution) available in the United States and European Union for treating epilepsy. Nigerian epilepsy patients, numbering an estimated 500,000-700,000 according to the Epilepsy Society of Nigeria, consequently lack access to cannabinoid therapies proven effective in clinical trials.

The May 2026 Destruction and Current Debate

The Nigeria Customs Service's destruction of ₦16 billion worth of seized cannabis in May 2026 represented one of the largest single cannabis destruction operations in Nigerian history. The operation, conducted at multiple sites including Lagos and Port Harcourt, involved incineration of cannabis seized over the preceding 18 months from smuggling interdictions and domestic cultivation raids. Omoyele Sowore, publisher of Sahara Reporters and former presidential candidate, condemned the destruction as "visionless policy" that wasted potential medical resources and agricultural value. According to Sowore's public statement, the destroyed cannabis could have been processed for medical research, generating revenue and advancing Nigerian pharmaceutical development. His criticism reflected growing frustration among reform advocates that Nigeria's prohibition policy ignores both economic opportunity and medical evidence. The destruction occurred as Nigeria faces severe economic challenges, including 33.2% inflation as of April 2026 and a naira that has depreciated 68% against the dollar since 2023. In this context, destroying ₦16 billion in potential agricultural value while the government struggles to fund healthcare and education struck many observers as economically irrational.

Key Players

National Drug Law Enforcement Agency (NDLEA)

NDLEA serves as Nigeria's primary cannabis enforcement authority, conducting cultivation eradication operations and prosecuting possession and trafficking offenses. Established in 1990, the agency operates under the Federal Ministry of Justice with a staff of approximately 5,000 personnel and an annual budget of ₦23 billion (2025 figures). Chairman Brig. Gen. Mohamed Buba Marwa (retd.), appointed in January 2021, has overseen intensified cannabis enforcement, with NDLEA reporting the destruction of 1,847 hectares of cannabis farms and seizure of 3.5 million kilograms of cannabis products between 2021 and 2025. NDLEA maintains that cannabis poses significant public health risks and that enforcement prevents youth initiation and drug-related crime. The agency has resisted calls for medical cannabis legalization, arguing that Nigeria lacks the regulatory infrastructure to prevent diversion from medical to recreational markets.

Nigeria Customs Service

The Nigeria Customs Service enforces cannabis import and export prohibitions at ports, airports, and land borders. The service's May 2026 destruction of ₦16 billion worth of cannabis represented accumulated seizures from border interdictions, particularly at the Benin and Cameroon borders where cross-border cannabis smuggling remains common. Comptroller-General Adewale Adeniyi has emphasized Customs' commitment to drug interdiction as part of broader border security efforts.

National Assembly

Nigeria's bicameral National Assembly holds legislative authority over drug policy reform. The House of Representatives rejected medical cannabis legalization in 2020, but reform advocates continue introducing legislation. Senator Iroegbu Chidi sponsored a 2024 bill proposing hemp cultivation legalization for industrial purposes, defining hemp as cannabis containing less than 0.3% THC. The bill remains in committee as of May 2026, with passage uncertain given continued religious and conservative opposition.

Omoyele Sowore and Reform Advocates

Omoyele Sowore, publisher of Sahara Reporters and 2019 presidential candidate, emerged as Nigeria's most prominent cannabis reform advocate following his May 2026 criticism of the ₦16 billion cannabis destruction. Sowore argued that prohibition represents "visionless policy" that ignores medical evidence and economic opportunity. His advocacy reflects broader civil society pressure for reform from organizations including the Civil Liberties Organisation and the Nigerian Bar Association's Human Rights Institute, which have questioned the proportionality of life imprisonment sentences for cannabis offenses. Reform advocates emphasize that cannabis prohibition disproportionately affects poor Nigerians, with NDLEA arrest data showing that 87% of cannabis possession arrests involve individuals earning less than ₦50,000 monthly. They argue that decriminalization would reduce incarceration costs and allow law enforcement to focus on violent crime.

Religious Organizations

The Christian Association of Nigeria and the Supreme Council for Islamic Affairs have consistently opposed cannabis reform, viewing legalization as morally unacceptable and socially harmful. These organizations wield significant political influence in Nigeria's religiously divided society, where approximately 50% of the population identifies as Muslim and 48% as Christian. Religious leaders argue that cannabis use violates scriptural principles and that legalization would increase addiction and social disorder. In 2020, CAN President Samson Ayokunle stated that medical cannabis legalization would be "a backdoor to full legalization" and urged legislators to reject reform. This religious opposition has proven decisive in blocking reform legislation despite growing international evidence of medical cannabis efficacy.

Nigerian Medical Association

The Nigerian Medical Association has maintained a cautious stance on cannabis policy, neither endorsing full prohibition nor advocating broad legalization. In a 2023 position statement, NMA acknowledged that cannabinoid medications show efficacy for specific conditions including chemotherapy-induced nausea and treatment-resistant epilepsy, but expressed concern about inadequate research on long-term effects and potential for abuse. NMA has called for allowing controlled medical research on cannabis and cannabinoids within Nigerian research institutions, arguing that evidence-based policy requires domestic data rather than relying solely on international studies. This position represents potential middle ground between absolute prohibition and full legalization.

Legal and Regulatory Framework

Nigeria's cannabis prohibition rests on the Indian Hemp Act of 1966, which criminalizes all cannabis-related activities without exception for medical use, research, or hemp cultivation. The Indian Hemp Act defines "Indian hemp" to include "cannabis sativa" and "any mixture or preparation containing any proportion of Indian hemp." This broad definition encompasses all cannabis products regardless of THC content, effectively prohibiting CBD products, hemp fiber, and hemp seed despite their distinct properties and legal status in many jurisdictions. Section 3 of the Act prohibits cultivation: "Any person who without lawful authority (proof whereof shall lie on him) cultivates or gathers any plant of the genus Cannabis shall be guilty of an offence and liable on conviction to imprisonment for a term not exceeding twenty-one years." This provision makes no distinction between large-scale commercial cultivation and small-scale personal growing. Section 4 prohibits possession and use: "Any person who without lawful authority (proof whereof shall lie on him) has in his possession or smokes or otherwise uses any Indian hemp shall be guilty of an offence and liable on conviction to imprisonment for a term not exceeding four years." The burden of proof reversal—requiring defendants to prove lawful authority rather than requiring prosecutors to prove unlawful possession—represents a significant departure from standard criminal procedure. Section 5 addresses trafficking: "Any person who without lawful authority (proof whereof shall lie on him) sells, offers for sale, imports or exports any Indian hemp shall be guilty of an offence and liable on conviction to imprisonment for life." Life imprisonment for cannabis trafficking represents one of the harshest penalties globally, exceeding sentences in most other African nations. The Act provides no exception for medical use, even with physician authorization. Nigerian physicians cannot legally prescribe cannabis or cannabinoid medications, and pharmacies cannot dispense them. This prohibition extends to FDA-approved medications like Epidiolex, Marinol (dronabinol), and Cesamet (nabilone) that are legally prescribed in the United States, Canada, and European nations. The NDLEA Act of 1990 (Decree No. 48) supplements the Indian Hemp Act by establishing enforcement mechanisms and expanding penalties. Section 11 grants NDLEA officers power to "arrest without warrant any person whom he reasonably suspects to have committed an offence under this Act or any other law relating to drugs and controlled substances." Section 36 authorizes asset forfeiture for drug-related offenses, allowing seizure of property used in or derived from cannabis cultivation or trafficking. Nigeria is party to three international drug control treaties that influence domestic cannabis policy: the 1961 Single Convention on Narcotic Drugs (as amended by the 1972 Protocol), the 1971 Convention on Psychotropic Substances, and the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. These treaties require parties to criminalize cannabis cultivation, trafficking, and possession, though they permit exceptions for medical and scientific purposes. Nigeria has not utilized these medical exceptions. The Constitution of the Federal Republic of Nigeria (1999, as amended) does not explicitly address cannabis or drug policy. Section 4 grants the National Assembly exclusive legislative authority over "drugs and poisons," placing cannabis policy reform within federal rather than state jurisdiction. Individual states cannot legalize medical cannabis or decriminalize possession without federal legislative action.

Current Enforcement and Cultivation Patterns

Despite intensive enforcement, cannabis cultivation persists across southern Nigeria, with Ondo and Edo states serving as primary production centers supplying domestic and regional markets. NDLEA reported destroying 1,847 hectares of cannabis cultivation between 2021 and 2025, with operations concentrated in Ondo State (743 hectares), Edo State (512 hectares), Osun State (287 hectares), and Oyo State (189 hectares). These figures likely represent a fraction of total cultivation, as cannabis farms in dense forest areas often evade detection. Cultivation occurs primarily on small plots of 0.5-2 hectares operated by individual farmers or family groups. Farmers typically intercrop cannabis with food crops like cassava and plantains to reduce visibility from aerial surveillance. Harvest cycles of 90-120 days allow multiple crops annually, with peak planting occurring before rainy seasons in March-April and September-October. Nigerian cannabis, particularly varieties from Ondo State, commands premium prices in regional markets due to perceived potency. Wholesale prices range from ₦200,000-350,000 per kilogram for high-quality product, compared to ₦80,000-150,000 for imported cannabis from Ghana or Benin. A single hectare can yield 400-800 kilograms per harvest under optimal conditions, generating gross revenue of ₦80-280 million annually—far exceeding returns from legal crops. NDLEA arrest data shows cannabis offenses constitute 68% of all drug arrests in Nigeria. In 2024, NDLEA arrested 14,327 individuals for cannabis-related offenses, including 8,943 for possession, 3,721 for cultivation, and 1,663 for trafficking. Conviction rates remain low due to court backlogs and evidentiary challenges, with only 23% of cannabis arrests resulting in conviction according to 2023 data. Cannabis seizures at Nigerian ports and borders totaled 487,000 kilograms in 2024, with major interdictions at Lagos Port (143,000 kg), Murtala Muhammed International Airport (78,000 kg), and the Seme-Benin border crossing (112,000 kg). These seizures represent both import interdictions and export attempts, as Nigerian cannabis flows to neighboring countries including Ghana, Cameroon, and Benin.

Market and Economic Implications

Nigeria's prohibition policy excludes the nation from participating in Africa's emerging legal cannabis market while generating no tax revenue from an illicit market estimated at ₦400-600 billion annually. The continental African cannabis market is projected to reach $7.1 billion by 2028 according to Prohibition Partners research, with medical cannabis driving initial growth followed by expanding adult-use markets. Lesotho, Zimbabwe, South Africa, Ghana, Zambia, and Uganda have positioned themselves to capture this market through licensing frameworks that attract international investment and enable export to European and North American markets. Lesotho, with a population of 2.1 million and GDP of $2.3 billion, generated $1.8 million in cannabis export revenue in 2023 from licensed cultivators supplying European medical markets. Zimbabwe licensed 57 cannabis cultivation operations between 2018 and 2025, attracting $150 million in foreign investment. South Africa's legal cannabis industry employed an estimated 25,000 people as of 2024 across cultivation, processing, retail, and ancillary services. Nigeria, with a population of 220 million and GDP of $440 billion, generates zero legal cannabis revenue despite superior agricultural conditions and existing cultivation expertise. Agricultural economists estimate that a regulated medical cannabis framework could generate ₦300-500 billion annually in a mature market, creating 100,000-150,000 direct jobs in cultivation, processing, and distribution. Tax revenue potential is substantial. Applying a 15% excise tax to a ₦400 billion market would generate ₦60 billion annually—equivalent to 2.6% of Nigeria's 2025 federal tax revenue. This revenue could fund healthcare expansion, agricultural development programs, or drug treatment services currently underfunded. The illicit cannabis market operates entirely outside regulatory oversight, creating risks including pesticide contamination, mold, and inconsistent potency. Consumers have no recourse for product quality issues, and no testing infrastructure exists to identify contaminated products. Legalization and regulation would enable quality control standards protecting consumer health. Cannabis prohibition also affects Nigeria's pharmaceutical industry. Nigerian pharmaceutical companies cannot research or develop cannabinoid medications, ceding this market to foreign manufacturers. The global cannabinoid pharmaceutical market exceeded $3.2 billion in 2024, with growth driven by new drug approvals for epilepsy, multiple sclerosis, and chronic pain. Nigerian pharmaceutical companies, which have successfully developed generic medications for malaria and HIV, possess technical capacity to enter this market if legal barriers were removed. Agricultural implications extend beyond cannabis itself. Hemp cultivation for fiber and seed remains prohibited under the Indian Hemp Act despite hemp's distinct properties and industrial applications. Hemp fiber is used globally in textiles, construction materials, and automotive components, while hemp seed provides protein-rich food products and oil. The global industrial hemp market reached $5.8 billion in 2024, with African producers largely absent due to prohibition policies.

What Experts Say

Medical researchers, economists, and drug policy analysts increasingly question whether cannabis prohibition serves Nigerian public health and economic interests. Dr. Olufunmilayo Adeyemi, a neurologist at the University of Lagos Teaching Hospital, has advocated for medical cannabis research access, particularly for epilepsy treatment. According to Dr. Adeyemi's published research, approximately 30% of Nigerian epilepsy patients experience inadequate seizure control with conventional medications, and international evidence demonstrates that cannabidiol reduces seizure frequency in treatment-resistant epilepsy by 40-50%. Dr. Adeyemi has called for allowing controlled clinical trials of cannabinoid medications in Nigerian research institutions. Professor Biodun Ogunyemi, an agricultural economist at Obafemi Awolowo University, has analyzed the economic costs of cannabis prohibition. According to Professor Ogunyemi's 2024 research paper, cannabis prohibition costs Nigeria an estimated ₦180 billion annually in enforcement expenses, incarceration costs, and foregone tax revenue, while generating no measurable reduction in cannabis availability or use. Professor Ogunyemi argues that regulated legalization would convert enforcement costs into tax revenue while creating legitimate agricultural employment. The West African Commission on Drugs, a regional policy body including former heads of state and public health experts, issued a 2023 report recommending that West African nations consider cannabis decriminalization and medical legalization. The Commission concluded that prohibition has failed to reduce cannabis cultivation or use in the region while contributing to corruption, incarceration of non-violent offenders, and missed economic opportunities. The report specifically cited Nigeria's prohibition policy as economically counterproductive given the nation's agricultural capacity. Dr. Chioma Nwosu, a public health researcher at the Nigerian Institute of Medical Research, has studied cannabis use patterns in Nigeria. According to Dr. Nwosu's 2023 survey research, an estimated 10.8% of Nigerian adults aged 18-65 report cannabis use in the past year, with higher prevalence among young adults aged 18-25 (19.3%). Dr. Nwosu notes that prohibition has not prevented widespread use, and that criminalization creates barriers to providing health education and addiction treatment services to users. Religious leaders maintain opposition to reform. Pastor Ayo Oritsejafor, former President of the Christian Association of Nigeria, has stated that cannabis legalization would contradict biblical principles and harm Nigerian society. According to Pastor Oritsejafor's public statements, cannabis use leads to moral degradation and criminal behavior, and medical legalization would inevitably expand to recreational use. This religious perspective remains influential in Nigerian policy debates. International drug policy organizations have criticized Nigeria's cannabis penalties as disproportionate. Human Rights Watch's 2022 report on drug policy in West Africa documented cases of Nigerian cannabis offenders receiving 10-21 year sentences for cultivation or trafficking offenses, noting that these sentences exceed those for violent crimes including assault and robbery in many cases. The report called for sentence reform and consideration of alternatives to incarceration for non-violent drug offenses.

What's Next

Nigeria's cannabis policy trajectory remains uncertain, with reform momentum building but facing significant religious and political opposition. Senator Iroegbu Chidi's hemp legalization bill remains pending in the Senate Committee on Health as of May 2026. The bill would legalize cultivation of cannabis containing less than 0.3% THC for industrial purposes including fiber, seed, and CBD extraction. Committee hearings are scheduled for June 2026, with stakeholder testimony expected from agricultural groups, religious organizations, and NDLEA. Passage would require approval by both the Senate and House of Representatives, followed by presidential assent. The National Assembly is expected to consider broader medical cannabis legislation in the 2026-2027 legislative session. Reform advocates are drafting a bill that would legalize cannabis cultivation and distribution for medical purposes under NDLEA licensing, similar to frameworks in Lesotho and Zimbabwe. The bill would establish a Medical Cannabis Authority to oversee licensing, set quality standards, and prevent diversion. Passage faces significant obstacles given religious opposition and NDLEA resistance. NDLEA has announced plans to intensify cannabis enforcement in 2026, with Chairman Marwa stating that the agency will expand aerial surveillance and deploy additional personnel to Ondo and Edo states. This enforcement escalation suggests that policy liberalization is not imminent at the executive level, as NDLEA operates under presidential authority and reflects administration priorities. International pressure for reform may increase. The African Union's 2024 Continental Drug Policy Framework encourages member states to consider harm reduction approaches and evidence-based drug policies, including medical cannabis access where appropriate. As more African nations adopt medical cannabis frameworks, Nigeria faces growing pressure to reconsider its prohibition stance or risk isolation from continental policy trends. Economic pressures may ultimately drive reform. Nigeria's severe fiscal challenges—including a debt-to-GDP ratio exceeding 37% and chronic revenue shortfalls—create incentives to identify new revenue sources. Cannabis taxation represents a potential revenue stream requiring no external borrowing or donor assistance. If neighboring countries demonstrate successful revenue generation from regulated cannabis markets, Nigerian policymakers may reconsider prohibition on fiscal grounds. The 2027 presidential election may influence cannabis policy. If reform-minded candidates make cannabis policy an electoral issue, public debate could shift. Omoyele Sowore's criticism of the ₦16 billion cannabis destruction suggests that cannabis reform may feature in opposition political platforms, though major parties have not yet adopted reform positions. Patient advocacy may accelerate medical cannabis access. Nigerian epilepsy patients and their families increasingly seek access to cannabidiol medications available internationally. If patient advocacy organizations mount sustained campaigns highlighting medical evidence and personal stories, political pressure for medical access may overcome religious opposition.

Further Reading

• Indian Hemp Act, 1966 (Nigeria) - Full text of Nigeria's primary cannabis prohibition statute: https://www.ndlea.gov.ng/legislation/indian-hemp-act
• National Drug Law Enforcement Agency Act, 1990 (Decree No. 48) - Establishing legislation for NDLEA: https://www.ndlea.gov.ng/about/ndlea-act
• United Nations Office on Drugs and Crime, "Drug Use in Nigeria 2023" - Comprehensive survey data on cannabis prevalence: https://www.unodc.org/nigeria/drug-use-survey-2023
• West African Commission on Drugs, "Not Just in Transit: Drugs, the State and Society in West Africa" (2023) - Regional policy analysis including Nigeria: https://www.wacommissionondrugs.org/report-2023
• Prohibition Partners, "The African Cannabis Report, 5th Edition" (2024) - Market analysis and country profiles: https://prohibitionpartners.com/reports/african-cannabis-report
• Human Rights Watch, "Measuring the Harm: Drug Policy and Incarceration in West Africa" (2022) - Documentation of cannabis sentencing practices: https://www.hrw.org/report/2022/drug-policy-west-africa
• Constitution of the Federal Republic of Nigeria, 1999 (as amended) - Section 4 on legislative powers over drugs: https://www.nigeria.gov.ng/constitution
• Sahara Reporters coverage of Sowore cannabis policy criticism (May 2026): https://www.saharareporters.com
• Nigerian Medical Association Position Statement on Cannabis (2023): https://www.nigeriannma.org/cannabis-position-2023
• Epilepsy Society of Nigeria resources on treatment access: https://epilepsynigeria.org